Certis Oncology Solutions

7 articles about Certis Oncology Solutions

• Certis Oncology Announces Closing of $10 Million Series C Fundraising Round

  1/17/2024

  Certis Oncology Solutions today announced that it raised $10 million in a Series C funding round, bringing total raised to $42 million.

• Certis Oncology Named 'Overall Immunology Company of the Year' in 2023 BioTech Breakthrough Awards

  11/9/2023

  Certis Oncology Solutions announced it has been selected as "Overall Immunology Company of the Year" in the third annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services.

• Certis Oncology Solutions Launches Predictive Analytics Platform

  4/13/2023

  Certis Oncology Solutions (“Certis”) today announced the launch of CertisAI™, a new predictive medicine platform that utilizes big data, statistical algorithms, and machine learning to predict drug efficacy based on gene expression biomarkers.

• Certis Oncology Releases New Cancer Model Database, BarneyOI™

  10/5/2022

  Certis Oncology Solutions, a life science technology company, announced today the release of its new cancer model database, BarneyOI™.

• CERTIS ONCOLOGY AWARDED AAALAC ACCREDITATION

  6/29/2022

  Certis provides high-precision translational drug discovery and development services to therapeutics innovators.

• Certis Oncology Offers Translational Science Services to Pharmaceutical Industry, Welcomes New Business Development Leader

  1/5/2021

  Certis Oncology Solutions, a precision oncology and translational sciences company, announced it will make available its personalized approach to drug efficacy testing to the commercial pharmaceutical industry.

• Certis Oncology Solutions Announces Mobile COVID-19 Testing

  7/9/2020

  Certis Oncology Solutions, a clinical research organization (CRO) and precision cancer therapy company, announced today it is offering mobile COVID-19 testing services to area businesses.